Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study

Changes in lung function and skin fibrosis within 12 months should be considered when evaluating risk of mortality. The effect of pharmacological treatments aiming at stabilization of these variables should be evaluated prospectively in clinical trials.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2025-06-03
DOI
https://doi.org/10.1093/rheumatology/keaf264
Citations
2
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
2.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study

Maria Üprus, Carlo Selmi, Anna‐Maria Hoffmann‐Vold, Vera Ortiz-Santamaría et al.
2 citations
Lara D. Veeken
Systemic Sclerosis and Related Diseases
2.94
article

Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study

Maria Üprus, Carlo Selmi, Anna‐Maria Hoffmann‐Vold, Vera Ortiz-Santamaría, Piotr Wiland, Edoardo Rosato, Svetlana Agachi, Ulrich A. Walker, Ivan Castellvi, Francesca Ingegnoli, Washington Bianchi, Leland W.K. Chung, Rosario Foti, Marie Vanthuyne, Tim Schmeiser, François Spertini, Florenzo Iannone, Vincent Sobanski, Alexandra Balbir‐Gurman, Gabriela Riemekasten, Dominique Farge Bancel, Eric HACHULLA, Francesco Paolo Cantatore, Carlomaurizio Montecucco, Ira Litinsky, Douglas J. Veale, Paloma García de la Peña Lefebvre, Elena Rezuş, Ruxandra Ionescu, Jörg H. W. Distler, Mohammed Tikly, Cecília Varjú, Kamal Solanki, Bojana Stamenković, Dörte Huscher, Paolo Airó, Marco Matucci‐Cerinic, Alessandro Giollo, Branimir Anić, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Dominik Majewski, D'Alessandro Mathieu, Simona Rednic, Yannick Allanore, Patricia E. Carreira, Bernard Coleiro, Juan José Alegre Sancho, Andrea Doria, Susanne Ullman, Şule Yavuz, Ellen De Langhe, Antonella Riccardi, Silvia Bellando-Randone, Ariane L. Herrick, Ana Maria Gheorghiu, Elise Siegert, Sarah Kahl, Vera Bernardino, Valeria Riccieri, Esthela Loyo, Kristine Herrmann, Stefan Heitmann, Mengtao Li, Oliver Distler, Francesco Del Galdo, Vivien Hsu, Otylia Kowal‐Bielecka, Radim Bečvář, Doron Rimar, Nils Schoof, Carlo Chizzolini, Codrina Ancuța, Britta Maurer, Konstantinos Fourlakis, Jean Sibilia, Peter M. Villiger, Eduardo Kerzberg, Jérôme Avouac, Thierry Martin, Lesley Ann Saketkoo, Vanessa Smith, Nemanja Damjanov, Lidia P Ananieva, László Czirják, Merete Engelhart, Christopher P. Denton, Maura Couto, Margarida Alves, Nihal Fathi, Jörg Henes
article en
2 citations

Abstract

Changes in lung function and skin fibrosis within 12 months should be considered when evaluating risk of mortality. The effect of pharmacological treatments aiming at stabilization of these variables should be evaluated prospectively in clinical trials.

Lara D. VeekenVol. 64(10)
Oslo University Hospital (NO), Ministry of Education of the People's Republic of China (CN), Medical University of Białystok (PL), Vita-Salute San Raffaele University (IT), Inserm (FR), Institut Universitaire de France (FR), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), University of Zurich (CH), Université Paris Cité (FR), Université de Lille (FR), Leiden University Medical Center (NL), Peking Union Medical College Hospital (CN), Sorbonne Paris Cité (FR), Hôpital Cochin (FR), Zimmer Biomet (Germany) (DE), University Hospital of Zurich (CH), Mylan (South Africa) (ZA), Lille Inflammation Research International Center (FR), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Institut Cochin (FR), Boehringer Ingelheim (China) (CN), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Institute for Translational Research in Inflammation (FR), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), Bayer (Germany) (DE), University of Pecs (HU), University of Lübeck (DE)
Boehringer Ingelheim, Pfizer, AstraZeneca, GlaxoSmithKline, Grifols, Genentech, Cilag
Good health and well-being
Openalex Percentile: Top 10%
Systemic Sclerosis and Related Diseases
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.